EFTRENONACOG ALFA
UNII 02E00T2QDE

Substance Identification & Data

This profile provides standardized clinical and technical data for Eftrenonacog Alfa, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 02E00T2QDE.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1270012-74-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

02E00T2QDE

CAS Registry Number

1270012-74-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

EFTRENONACOG ALFA

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

02E00T2QDE

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C171659

National Cancer Institute reference terminology for clinical and research data.

INN ID

9660

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Eftrenonacog Alfa. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EFTRENONACOG ALFA

Common Names & Synonyms

BLOOD-COAGULATION FACTOR IX (SYNTHETIC HUMAN) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (SYNTHETIC HUMAN FC DOMAIN FRAGMENT), (421-6'),(424-9')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (SYNTHETIC HUMAN FC DOMAIN FRAGMENT)

COAGULATION FACTOR IX RECOMBINANT IMMUNOGLUBULIN G1 FUSION PROTEIN

EFTRENONACOG ALFA [INN]

EFTRENONACOG ALFA [JAN]

EFTRENONACOG ALFA [MI]

EFTRENONACOG ALFA [WHO-DD]

RFIXFC